The MDconnect Screening System is a quantitative test that can be used to evaluate neuropathies, manage pharmacological treatments, and help identify possible malingerers. It provides fast, accurate, and straightforward results in 10 minutes to efficiently diagnose and monitor chronic pain patients presenting with conditions like CRPS, neuropathy, or those taking chronic opioids. The test measures parasympathetic and sympathetic response at rest and under stress to distinguish normal, psychosomatic, and CRPS pain, quantify severity, and monitor changes over time or with treatment.